Metformin-Associated Lactic Acidosis
Metformin-associated lactic acidosis is severe lactic acidosis (lactate over 5 mmol/L with pH under 7.35) occurring in a patient taking metformin. It is rare, with an incidence of 3 to 10 cases per 100,000 patient-years, but mortality is 25 to 50% when severe. Metformin is renally excreted and is not metabolized. It inhibits mitochondrial complex I and gluconeogenesis, so lactate production rises and its hepatic clearance falls.
Precipitants
- Acute kidney injury or chronic kidney disease (the most important, with eGFR under 30 mL/min/1.73 m2)
- Sepsis, hypoperfusion, acute heart failure, hypoxia and cardiac arrest
- Iodinated contrast exposure, dehydration and gastroenteritis
- Liver disease and heavy alcohol use
- Acute overdose (over 5 g in adults, or over 100 mg/kg)
Two settings exist: metformin-associated (accumulation with a coexisting illness) and metformin-induced (acute massive overdose). Complications: multiorgan failure, refractory shock, cardiac arrest, hypoglycemia and death.













